Tadliq is a liquid formulation of tadalafil approved in the U.S. to improve exercise ability in people with pulmonary ...

Cereno Scientific (NASDAQ First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that ...

As the world marks Rare Disease Month, health experts are calling attention to conditions that often go unnoticed—despite their life-threatening impact. One such condition is Pulmonary Arterial ...

A new study published in the Journal of the American Medical Association showed that using retinal scans of premature infants ...

AI echocardiography using multimodal right ventricular assessment predicted mortality in pulmonary hypertension. Learn more.

Winrevair, also known as sotatercept-csrk, is a medicine used to treat pulmonary arterial hypertension (PAH), which causes high blood pressure in the arteries that go from your heart to your lungs.

By the end of August, Heidi had a confirmed diagnosis of pulmonary arterial hypertension (PAH), a specific type of pulmonary hypertension that affects the arteries of the lungs and strains the right ...

Pulmonary arterial hypertension (PAH) is a type of high blood pressure in the arteries in your lungs. It happens when these arteries become narrow or blocked, making it harder for blood to flow ...

Mere weeks after earning the FDA’s signoff on new drug Winrevair to treat pulmonary arterial hypertension (PAH), Merck has kicked off an educational campaign around the rare disease. The “Outnumber ...

Panelists discuss how prostacyclin pathway treatments remain important but challenging due to significant side effects and delivery complexity, with sotatercept potentially reducing reliance on ...

Cereno Scientific (Nasdaq First North: CRNO B), an innovative biotech pioneering treatments to enhance and extend life for people with rare cardiovascular and pulmonary diseases, today announced that ...